The increased availability of generics combined with CVS Caremark's generic dispensing rate of 77.4% helped reduce spending on traditional medications by 3.6% for the company's commercial clients, according to its newly released annual insights report.

A majority of Americans say chronic pain ranks far below drug addiction as a major health problem, according to a new poll.

A desire to save money is driving younger and older adults to request cheaper drugs from their doctors, but it's also driving younger adults not to take their drugs as prescribed, according to a new study.

An experimental drug developed by AstraZeneca for rheumatoid arthritis produced mixed results in measurements of patients' conditions, according to results of a late-stage clinical trial.

Teva Pharmaceutical Industries has launched a generic opioid medication for treating pain, the company said.

Swiss drug maker Covis Pharma will buy U.S. rights to five drugs from Sanofi, Covis said.

The Food and Drug Administration has given preliminary approval to a drug made by Aurobindo Pharma for treating HIV infection, the drug maker said.

Novartis is promoting the multiple sclerosis drug Gilenya to young people with a new ad campaign in several national magazine's and websites, according to published reports.

Centene Corp. has purchased specialty pharmacy provider AcariaHealth for a combination of cash and stock, Centene said Tuesday.

A coalition of drug and pharmacy organizations formed to address patients' medication needs during disasters is changing the name and Web address of its reporting system to make it easier to remember, the organization said Tuesday.

The Food and Drug Administration is seeking comment from drug makers and others concerning formal meetings between the agency and companies looking to market follow-on biologics.

The Food and Drug Administration has approved a new treatment for multiple sclerosis made by Biogen Idec, the agency said.